Tetntative Program

ACTC 2014 TENTATIVE PROGRAM


Day 1

Day 2

Day 3

Day 4



DAY 4: Saturday, October 11

Time Session/Title Confirmed Speaker
Saturday, October 11
8:30 – 10:30
Plenary Lecture Session 5:
Clinical Significance of CTCs Lung, ovarian, and gastric cancer
8:30 – 9:00
PL5-1
The versatility of CTCs in Lung cancer - biomarkers, drug development and mouse models Caroline Dive, PhD, Senior Group Leader at the Paterson Institute for Cancer Research and Professor of Pharmacology at The University of Manchester, UK
9:00 – 9:30
PL5-2
Tumor infiltrating immune cells: do they influence tumor cell spread in gynecological cancers? Sabine Kasimir-Bauer, PhD, Professor, Head of Laboratory, Dep. of Gynecology and Obstetrics, University Hospital of Essen, Germany
9:30 – 10:00
PL5-3
Cancer stem cell of digestive organs Masaki Mori, MD, PhD, FACS, Chairman Professor of Surgery, Graduate School of Medicine, Osaka University, Japan
10:00 – 10:00
PL5-4
How tumor initiation shapes the metastatic behavior of cancer cells Yibin Kang, PhD, Warner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton University, Princeton, New Jersey, USA
10:30 – 11:30

Networking Coffee Break in the Exhibition Hall

11:00 – 12:30
Plenary Lecture Session 6:
Novel liquid biopsy biomarkers
11:00 – 11:30
PL6-1
New approaches to assessing different forms of free circulating nucleic acids in blood Dave Hoon, Director, Department of Molecular Oncology, John Wayne cancer Institute, Santa Monica, CA, USA
11:30 – 12:00
PL6-2
Circulating tumor cells and circulating tumor DNA- emerging roles in cancer monitoring and therapy Stefanie S. Jeffrey, MD, Professor of Surgery, Stanford, USA
12:00 – 12:30
PL6-3
Clinical Development and Qualification of Cancer Biomarkers for Specific Contexts of Use Gary J. Kelloff, M.D., Special Advisor, DCTD, NCI, NIH, and Chair Cancer Biomarker Consortium, FNIH
12:30 – 13:30
Presentation of awards - Closing Remarks
12:30 – 13:10 TRAVEL AWARDS ORAL PRESENTATIONS

12:3 0 – 12:40: O4-1

Whole exome sequencing of circulating tumor cells as a window into metastatic cancer

Jens G. Lohr, Viktor A. Adalsteinsson, Kristian Cibulskis et al,

1The Eli and Edy the Broad Institute, Cambridge, Massachusetts 02412, USA

2Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA

3Harvard Medical School, Boston, Massachusetts 02115, USA

12:40 – 12:50: O4-2

Single-cell metabolomics in circulating tumor cells

Laura Sarah Sasportas1, Silvan Tuerkcan2, Guillem Pratx2, Sanjiv Sam Gambhir1

1 Departments of Bioengineering and Radiology, Stanford University, Stanford, CA, United States.

2Department of Radiation Oncology, Stanford University, Stanford, CA, United States.

12:50 – 13:00: O4-3

Utilising circulating tumour cells to investigate molecular status and heterogeneity in small cell lung cancer.

Louise Carter 1, Dominic G Rothwell 1, Yaoyong Li 2, et al,

1 Clinical and Experimental Pharmacology, Cancer Research UK Manchester Institute, Manchester, UK. 2 RNA Biology Group/ Computational Biology, Cancer Research UK Manchester Institute, Manchester, UK. 3 Christie NHS Foundation Trust, Manchester, UK. 4 Institute of Cancer Sciences, University of Manchester, Manchester, UK.

13:00 – 13:10: O4-4

Analysis of disseminated tumor cells before and after chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?

Issam Chebouti1, Christina Blassl2, Paulina Wimberger3 et al

1 Dep. of Gynecology and Obstetrics, University Essen (Germany), 2 Dep. of Gynecology and Obstetrics, University Duesseldorf (Germany), 3Dep. of Gynecology and Obstetrics, University Dresden (Germany)

13:10 – 13:30

Presentation of travel awards

Presentation of best poster and oral presentations awards

Closing Remarks


Evi Lianidou, Dimitris Mavroudis , Klaus Pantel

13:30 – 14:30 Launch Break
AFTERNOON EXCURSION Visit to KNOSSOS Visit to the Archaeological Museum of Heraklion Free evening